Trade receivables increased 135.4%
Trade receivables changed +135.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Trade receivables changed +135.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -660 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Cash & equivalents changed -67.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed +2619 basis points from the comparable as-filed period.
Revenue changed +74.5% from the comparable as-filed period.
Total assets changed -37.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current assets changed -40.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Inventory / revenue changed -11413 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash flow changed +11.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Research & development changed -47.0% from the comparable as-filed period.
Shares outstanding changed +88.2% from the comparable as-filed period. The change ranks at the 43th percentile of 7 prior comparable changes.
Cost of revenue changed +29.8% from the comparable as-filed period.
SBC / revenue changed -1011 basis points from the comparable as-filed period.
Receivables / revenue changed +349 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital changed -42.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current ratio changed -35.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating cash-flow margin changed +18093 basis points from the comparable as-filed period.
R&D / revenue changed -3225 basis points from the comparable as-filed period.
Gross profit changed +2014.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Current liabilities changed -7.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +15.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Inventory changed +5.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.